期刊
NANO TODAY
卷 4, 期 5, 页码 382-384出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.nantod.2009.07.002
关键词
Opinion; Nanomedicine; HIV/AIDS; Cancer; Toxicology
资金
- EPSRC [EP/G066272/1] Funding Source: UKRI
- Engineering and Physical Sciences Research Council [EP/G066272/1] Funding Source: researchfish
Nanomedicine offers many benefits for the future treatment of disease conditions. The development of a nanomedicine may take different approaches but considerations of the disease, clinical practice, patient compliance and risk/benefit profiles are key to selecting the appropriate technologies. (C) 2009 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据
分享论文
